Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development 2024-03-09 18:17
"AXA Women's Health Centre" officially unveils on International Women's Day 2024-03-08 19:49
Launching Bneuron - A Breakthrough Dairy Supplement For Brain Protection 2024-03-08 17:14
Uniting for Women's Wellness on IWD - From China to Uzbekistan 2024-03-08 08:07
Pudu Robotics to Showcase Comprehensive Solutions at Australian Healthcare Week 2024-03-08 08:00
P2G Foundation is Leading the Charge in Empowering Singapore's Homeless Population 2024-03-07 15:19
Innovent released the results of two clinical studies of IBI311 (an anti-IGF-1R monoclonal antibody) in oral presentations at the Asia-Pacific Academy of Ophthalmology Congress and International Congress of Endocrinology 2024 2024-03-07 11:53
Luye Pharma's Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao 2024-03-07 10:11
A Global Milestone in Innovative Pancreatic Cancer Therapy 2024-03-07 10:00
Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance 2024-03-07 09:00
APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation 2024-03-06 20:22
Latest Updates of Viva Biotech's Portfolio Companies 2024-03-06 19:33
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya 2024-03-06 18:48
MAG GROUP HOLDING RECORDS OVER AED 12.6 BILLION SALES IN 2023 2024-03-06 18:00
NIPPON EXPRESS HOLDINGS Acquires Stake in Instalimb, Japan's Startup Expanding 3D-printed Prosthetics Business Overseas 2024-03-06 14:00
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision 2024-03-06 12:29
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024 2024-03-06 08:59
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms 2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
1 74 75 76 77 78 810